As of 2026-07-20, the EV/EBITDA ratio of AnaptysBio Inc (ANAB) is -45.03. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. AnaptysBio's latest enterprise value is 1,703.07 mil USD. AnaptysBio's TTM EBITDA according to its financial statements is -37.82 mil USD. Dividing these 2 quantities gives us the above AnaptysBio EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 8.5x - 16.1x | 12.4x |
| Forward P/E multiples | 10.4x - 16.5x | 14.8x |
| Fair Price | (14.02) - (21.45) | (18.17) |
| Upside | -124.2% - -137.0% | -131.3% |
| Date | EV/EBITDA |
| 2026-07-17 | -45.03 |
| 2026-07-16 | -42.07 |
| 2026-07-15 | -43.35 |
| 2026-07-14 | -48.50 |
| 2026-07-13 | -54.11 |
| 2026-07-10 | -51.48 |
| 2026-07-09 | -51.64 |
| 2026-07-08 | -50.68 |
| 2026-07-07 | -52.20 |
| 2026-07-06 | -48.34 |
| 2026-07-02 | -49.20 |
| 2026-07-01 | -50.74 |
| 2026-06-30 | -52.34 |
| 2026-06-29 | -51.16 |
| 2026-06-26 | -48.99 |
| 2026-06-25 | -46.32 |
| 2026-06-24 | -45.40 |
| 2026-06-23 | -46.13 |
| 2026-06-22 | -46.56 |
| 2026-06-18 | -44.65 |
| 2026-06-17 | -44.08 |
| 2026-06-16 | -44.73 |
| 2026-06-15 | -46.19 |
| 2026-06-12 | -43.54 |
| 2026-06-11 | -42.13 |
| 2026-06-10 | -40.49 |
| 2026-06-09 | -40.13 |
| 2026-06-08 | -39.92 |
| 2026-06-05 | -39.16 |
| 2026-06-04 | -40.16 |
| 2026-06-03 | -39.83 |
| 2026-06-02 | -39.84 |
| 2026-06-01 | -41.29 |
| 2026-05-29 | -43.23 |
| 2026-05-28 | -44.27 |
| 2026-05-27 | -44.79 |
| 2026-05-26 | -44.85 |
| 2026-05-22 | -46.34 |
| 2026-05-21 | -46.88 |
| 2026-05-20 | -46.63 |
| 2026-05-19 | -46.39 |
| 2026-05-18 | -45.60 |
| 2026-05-15 | -48.99 |
| 2026-05-14 | -48.25 |
| 2026-05-13 | -48.63 |
| 2026-05-12 | -50.86 |
| 2026-05-11 | -52.66 |
| 2026-05-08 | -53.74 |
| 2026-05-07 | -51.92 |
| 2026-05-06 | -52.23 |